MedTrace Logo

A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

NCT02539537 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2024-01-09

No results posted yet for this study

Summary

French national multicentric phase III trial evaluating chemotherapy with Folfirinox or gemcitabine in locally advanced pancreatic carcinoma.

Conditions

Interventions

DRUG

Gemcitabine

DRUG

Folinic Acid

DRUG

5-Fluoro-uracil

DRUG

Oxaliplatin

DRUG

Irinotecan

DRUG

L-folinic

Sponsors & Collaborators

  • UNICANCER

    lead OTHER

Principal Investigators

  • Michel DUCREUX, Professor · Gustave Roussy, Cancer Campus, Grand Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-23
Primary Completion
2022-02-28
Completion
2023-09-25

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02539537 on ClinicalTrials.gov